| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1517/17425247.5.9.1039 |
| P698 | PubMed publication ID | 18754752 |
| P2093 | author name string | Antonio Cutino | |
| Frances E Kane | |||
| Judith Burdan | |||
| Kenneth E Green | |||
| P433 | issue | 9 | |
| P921 | main subject | eye disease | Q3041498 |
| P304 | page(s) | 1039-1046 | |
| P577 | publication date | 2008-09-01 | |
| P1433 | published in | Expert Opinion on Drug Delivery | Q5421203 |
| P1476 | title | Iluvien: a new sustained delivery technology for posterior eye disease | |
| P478 | volume | 5 |
| Q89767577 | Advances in ocular drug delivery systems |
| Q37763871 | Biodegradable implants for sustained drug release in the eye. |
| Q37682216 | Biodegradable intraocular therapies for retinal disorders: progress to date |
| Q26749730 | Birdshot chorioretinopathy: current knowledge and new concepts in pathophysiology, diagnosis, monitoring and treatment |
| Q37412317 | Birdshot uveitis: current and emerging treatment options |
| Q41988259 | Comment on: "Use of the Fluocinolone Acetonide Intravitreal Implant for the Treatment of Noninfectious Posterior Uveitis: 3-Year Results of a Randomized Clinical Trial in a Predominantly Asian Population". |
| Q38143069 | Critical assessment of implantable drug delivery devices in glaucoma management |
| Q52632539 | Current Advances in Pharmacotherapy and Technology for Diabetic Retinopathy: A Systematic Review. |
| Q30478379 | Drug delivery to the posterior segment of the eye for pharmacologic therapy |
| Q89002608 | Effectiveness of the Dexamethasone Intravitreal Implant for Treatment of Patients with Diabetic Macular Oedema |
| Q36088924 | Efficacy and safety of sustained-delivery fluocinolone acetonide intravitreal implant in patients with chronic diabetic macular edema insufficiently responsive to available therapies: a real-life study |
| Q35794470 | Efficacy and tolerability of bilateral sustained-release dexamethasone intravitreal implants for the treatment of noninfectious posterior uveitis and macular edema secondary to retinal vein occlusion |
| Q36013578 | Elevated Intraocular Pressure After Intravitreal Steroid Injection in Diabetic Macular Edema: Monitoring and Management |
| Q86953268 | Evaluation of a perforated drug delivery system in mice for prolonged and constant release of a hydrophilic drug |
| Q26852189 | Fluocinolone acetonide (ILUVIEN®) micro-implant for chronic diabetic macular edema |
| Q64968920 | Hyaluronic acid modified MPEG-b-PAE block copolymer aqueous micelles for efficient ophthalmic drug delivery of hydrophobic genistein. |
| Q39767319 | In vivo and in vitro sustained release of ranibizumab from a nanoporous thin-film device. |
| Q35518911 | In vivo ocular fluorophotometry: delivery of fluoresceinated dextrans via transscleral diffusion in rabbits |
| Q58806282 | Intravitreal therapeutic agents in noninfectious uveitic macular edema |
| Q34892662 | Local therapies for inflammatory eye disease in translation: past, present and future |
| Q37692245 | New techniques for drug delivery to the posterior eye segment |
| Q38211433 | Novel Intraocular Therapy in Non-infectious Uveitis of the Posterior Segment of the Eye. |
| Q37395756 | Ophthalmic drug delivery: development and regulatory considerations. |
| Q33523991 | Optimal current and future treatments for diabetic macular oedema |
| Q89366267 | Optimising drug therapy for non-infectious uveitis |
| Q34274075 | Pharmacotherapy for uveitis: current management and emerging therapy |
| Q36198990 | Reservoir-based drug delivery systems utilizing microtechnology |
| Q35835614 | Sustained release intraocular drug delivery devices for treatment of uveitis |
| Q36676772 | Targeting inflammation in emerging therapies for genetic retinal disease |
| Q35852620 | Ultrathin Polyimide Membrane as Cell Carrier for Subretinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigment Epithelium |
| Q28552652 | sFlt Multivalent Conjugates Inhibit Angiogenesis and Improve Half-Life In Vivo |
Search more.